Kilitch Drugs (India) Limited (KILITCH)
ISIN: - Industry: Drug Manufacturers—Specialty & Generic Sector: Healthcare Website
156.2
-2.7(-1.7%)

Kilitch Drugs (India) Limited engages in the development and operation of pharmaceutical business in India. The company offers parenteral and nasal products, including gastroenterology, anti-inflammatory, anticonvulsant/antiepileptic, anti-malarial, aminoglycoside, antibacterial, anti-hypertensive, anti-infective, diagnostic, sympathomimetic, local anesthetic, neurotonic, uterine stimulant, external preparation, non-steroidal anti-inflammatory, oncology, ophthalmic, and other drugs, as well as vaccines and veterinary products in the form of ampoules, vials, and dry powder injectables. Its parenteral and nasal products also include iron supplements for the treatment of anemia; and metered nasal drops, as well as Klavmox and Onecef products. The company also provides a range of oral formulations, including tablets, capsules, dry syrup, gripe water, and oral powder and liquid in the antibiotic, anti-diabetics, cardiovascular, and other areas. In addition, it offers effervescent tablets and powders, such as ROIPAR, DUREGRA, ROIVIT, and PH-7; and various nutritional products, such as CELTINE. Further, the company provides C-Seal, a topical skin adhesive to hold closely approximated skin edges without marks of sutures and incisions. Additionally, it offers cosmetics and herbal products consisting of a range of oils, lotions, liquids, creams, and paste in skin, personal, and hair care categories, as well as herbal products used in sore throat and prostate problems; and as a supplement for diabetes, obesity, libido, and other conditions. The company also exports its products. Kilitch Drugs (India) Limited was founded in 1978 and is headquartered in Mumbai, India.

Pricing Updates

TODAY'S HIGH

162

TODAY'S LOW

155.2

52 WEEK HIGH

275.1

52 WEEK LOW

145

Major Holders

% of Shares Held by
All Insider

72.81%

% of Shares Held by
Institutions

0.00%

% of Float Held by
Institutions

0.00%

Number of Institutions
Holding Shares

0

Company Overview

MARKET CAP

243.93 Cr.

ETERPRISE VALUE

211.94 Cr.

NO. OF SHARES

1.55 Cr.

BOOK VALUE

93.006

DIV. YIELD

0.5%

DEBT

18.93 Cr.

GROSS PROFIT

47.29 Cr.

CASH

54.37 Cr.

REVENUE

135.18 Cr.

REVENUE/SHARE

86.817

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Investments-6.87 Cr.-27.20 Lakhs31.03 Lakhs3.85 Cr.
Change To Liabilities22.71 Cr.46.56 Cr.2.84 Cr.-3.19 Cr.
Total cashflows from Investing Activities-15.25 Cr.-37.56 Cr.-10.45 Cr.-13.97 Cr.
Net Borrowings5.62 Cr.2.19 Cr.3.15 Cr.8.53 Cr.
Total Cash from Financing Activities7.02 Cr.1.61 Cr.84.95 Lakhs16.85 Cr.
Other Liabilities-6.19 Cr.-1.11 Cr.-1.18 Cr.41.14 Lakhs
Total Assets8.78 Lakhs6.04 Lakhs7.90 Lakhs7.04 Cr.
Net Income7.36 Cr.3.67 Cr.84.20 Lakhs3.82 Cr.
Change in Cash-2.43 Cr.9.70 Cr.-5.14 Cr.3.16 Cr.
Effect of Exchange Rate0000
Total Cash from Operating Activities5.78 Cr.45.65 Cr.4.46 Cr.29.09 Lakhs
Depreciation2.46 Cr.1.14 Cr.1.15 Cr.1.19 Cr.
Other Cashflows from Investing Activities-17.38 Lakhs-99.93 Lakhs-26.49 Lakhs1.19 Cr.
Dividends Paid00-1.79 Cr.-95.04 Lakhs
Change to Inventory-1.41 Cr.1.97 Cr.-84.09 Lakhs-1.91 Cr.
Change to Account Receivables-20.29 Cr.-8.66 Cr.5.51 Cr.-1.28 Cr.
Other Cashflows from Financing Activities1.31 Cr.-64.08 Lakhs-59.42 Lakhs2.22 Cr.
Change to Net Income1.13 Cr.2.09 Cr.-3.86 Cr.1.23 Cr.
Capital Expenditures-8.20 Cr.-36.29 Cr.-10.49 Cr.-19.02 Cr.

Financials

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax9.61 Cr.5.11 Cr.1.60 Cr.8.58 Cr.
Minority Interest1.20 Cr.2.35 Cr.2.21 Cr.2.09 Cr.
Net Income7.90 Cr.4.13 Cr.-84.38 Lakhs6.86 Cr.
Selling General Administrative11.66 Cr.10.40 Cr.11.36 Cr.12.12 Cr.
Gross Profit48.80 Cr.30.61 Cr.23.54 Cr.33.47 Cr.
Ebit7.90 Cr.4.13 Cr.-84.38 Lakhs6.86 Cr.
Operating Income7.90 Cr.4.13 Cr.-84.38 Lakhs6.86 Cr.
Other Operating Expenses26.76 Cr.14.92 Cr.11.87 Cr.9.46 Cr.
Interest Expense-1.19 Cr.-75.44 Lakhs-71.59 Lakhs-37.91 Lakhs
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense3.40 Cr.1.35 Cr.76.53 Lakhs4.75 Cr.
Total Revenue114.23 Cr.68.52 Cr.53.32 Cr.82.48 Cr.
Total Operating Expenses106.33 Cr.64.38 Cr.54.16 Cr.75.62 Cr.
Cost of Revenue65.43 Cr.37.91 Cr.29.77 Cr.49.01 Cr.
Total Other Income Expense Net1.71 Cr.98.55 Lakhs2.45 Cr.1.71 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.6.21 Cr.3.76 Cr.84.20 Lakhs3.82 Cr.
Net Income Applicable to Common Shares7.36 Cr.3.67 Cr.84.20 Lakhs3.82 Cr.

Balance Sheet

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Intangible Assets21.29 Cr.15.40 Lakhs5.01 Lakhs2.89 Lakhs
Capital Surplus038.32 Cr.38.32 Cr.38.32 Cr.
Total Liabilities69.55 Cr.73.69 Cr.22.36 Cr.20.50 Cr.
Stock Holder Equity139.08 Cr.127.12 Cr.118.25 Cr.121.05 Cr.
Minority Interest1.20 Cr.2.35 Cr.2.21 Cr.2.09 Cr.
Other Liabilities4.96 Cr.3.22 Cr.74.91 Lakhs4.29 Cr.
Total Assets209.84 Cr.203.17 Cr.142.83 Cr.143.66 Cr.
Common Stock15.58 Cr.15.49 Cr.15.43 Cr.15.35 Cr.
Retained Earnings067.61 Cr.63.26 Cr.63.35 Cr.
Other Liabilities27.54 Lakhs38.06 Lakhs38.80 Lakhs41.34 Lakhs
Good Will021.90 Cr.22.74 Cr.23.59 Cr.
Treasury Stock123.50 Cr.5.69 Cr.1.22 Cr.4.02 Cr.
Other Assets1.97 Cr.1.72 Cr.1.32 Cr.1.37 Cr.
Cash10.06 Cr.12.50 Cr.2.79 Cr.7.94 Cr.
Current Liabilities69.27 Cr.73.31 Cr.21.97 Cr.20.09 Cr.
Long Term Asset Charges1.51 Cr.1.27 Cr.96.62 Lakhs1.03 Cr.
Short Long Term Debt0000
Other Stockholder Equity123.50 Cr.5.69 Cr.1.22 Cr.4.02 Cr.
Property Plant Equipment46.40 Cr.73.38 Cr.38.33 Cr.28.76 Cr.
Total Cur. Assets114.10 Cr.80.36 Cr.55.78 Cr.64.87 Cr.
Long Term Investments26.06 Cr.25.64 Cr.24.58 Cr.25.01 Cr.
Net Tangible Assets117.78 Cr.105.06 Cr.95.45 Cr.97.43 Cr.
Short Term Investments47.23 Cr.36.40 Cr.27.81 Cr.28.41 Cr.
Net Receivables41.43 Cr.22.93 Cr.15.88 Cr.19.54 Cr.
Long Term Debt0000
Inventory5 Cr.3.58 Cr.5.55 Cr.4.71 Cr.
Accounts Payable42.86 Cr.53.65 Cr.7.10 Cr.4.34 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account